DocuSign, Inc. (LON:0XNH)

Verve Therapeutics Ratios and Metrics

Market cap in millions GBP. Fiscal year is February - January.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jul 31, 2025	Jan 31, 2025	Jan 31, 2024	Jan 31, 2023	Jan 31, 2022	Jan 31, 2021
Market Capitalization	11,264	15,721	9,770	9,899	18,543	32,475
Market Cap Growth	34.19%	60.91%	-1.29%	-46.62%	-42.90%	204.06%
Enterprise Value	10,648	15,068	9,177	9,787	18,605	32,538
Last Close Price	55.48	78.10	48.10	48.75	92.02	168.19
PE Ratio	13.58	18.30	167.92	-	-	-
PS Ratio	4.96	6.57	4.50	4.85	11.81	30.65
PB Ratio	7.45	9.76	11.00	19.75	90.33	136.74
P/TBV Ratio	10.08	13.28	17.12	63.05	-	-
P/FCF Ratio	-	21.23	14.00	28.42	55.92	207.60
P/OCF Ratio	-	19.21	12.68	24.06	49.14	150.00
EV/Sales Ratio	4.65	6.29	4.22	4.79	11.85	30.71
EV/EBITDA Ratio	44.06	65.35	95.09	1516.61	1684.00	-
EV/EBIT Ratio	58.17	80.05	185.98	-	-	-
EV/FCF Ratio	15.50	20.35	13.15	28.10	56.10	208.00
Debt / Equity Ratio	0.07	0.06	0.13	1.44	3.20	2.81
Debt / EBITDA Ratio	0.42	0.40	0.95	21.59	17.92	-
Debt / FCF Ratio	0.14	0.14	0.16	2.07	1.98	4.27
Asset Turnover	0.88	0.85	0.92	0.91	0.86	0.69
Quick Ratio	0.73	0.77	0.90	0.71	0.92	1.02
Current Ratio	0.79	0.81	0.94	0.74	0.96	1.06
Return on Equity (ROE)	70.20%	68.18%	8.47%	-21.83%	-23.28%	-55.79%
Return on Assets (ROA)	4.41%	4.19%	1.31%	-1.32%	-1.46%	-5.14%
Return on Capital (ROIC)	8.86%	8.60%	2.82%	-2.75%	-2.96%	-8.92%
Return on Capital Employed (ROCE)	11.00%	10.70%	4.80%	-	-	-
Earnings Yield	7.37%	5.46%	0.60%	-0.80%	-0.28%	-0.55%
FCF Yield	6.10%	4.71%	7.14%	3.52%	1.79%	0.48%
Buyback Yield / Dilution	-0.79%	-0.66%	-4.00%	-2.15%	-5.88%	-5.13%

Updated Mar 18, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.